Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.340
-0.010 (-0.43%)
At close: Aug 7, 2025, 4:00 PM
2.370
+0.030 (1.28%)
Pre-market: Aug 8, 2025, 8:21 AM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $796.22 million as of August 8, 2025. Its market cap has decreased by -2.38% in one year.
Market Cap
796.22M
Enterprise Value
246.26M
1-Year Change
-2.38%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $796.22M, an increase of 356.34%. That is a compound annual growth rate of 35.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 796.22M | -11.06% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
| Aug 26, 2020 | 174.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |